Merrimack Pharmaceuticals Inc (MACK)
15.00
-0.03
(-0.20%)
USD |
NASDAQ |
May 03, 16:00
15.00
0.00 (0.00%)
After-Hours: 20:00
Merrimack Pharmaceuticals Cash from Operations (Quarterly): -0.295M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.295M |
| September 30, 2023 | -0.203M |
| June 30, 2023 | -0.668M |
| March 31, 2023 | -0.356M |
| December 31, 2022 | -0.185M |
| September 30, 2022 | -0.264M |
| June 30, 2022 | -0.939M |
| March 31, 2022 | -0.354M |
| December 31, 2021 | -0.355M |
| September 30, 2021 | -0.445M |
| June 30, 2021 | 1.019M |
| March 31, 2021 | -0.437M |
| December 31, 2020 | -1.776M |
| September 30, 2020 | 0.135M |
| June 30, 2020 | -1.979M |
| March 31, 2020 | -1.005M |
| December 31, 2019 | -2.64M |
| September 30, 2019 | -3.203M |
| June 30, 2019 | -11.87M |
| March 31, 2019 | -13.65M |
| December 31, 2018 | -18.89M |
| September 30, 2018 | -13.11M |
| June 30, 2018 | -16.24M |
| March 31, 2018 | -17.34M |
| December 31, 2017 | -24.79M |
| Date | Value |
|---|---|
| September 30, 2017 | -25.64M |
| June 30, 2017 | -65.23M |
| March 31, 2017 | -10.16M |
| December 31, 2016 | -30.90M |
| September 30, 2016 | -34.92M |
| June 30, 2016 | -50.90M |
| March 31, 2016 | -53.52M |
| December 31, 2015 | -3.308M |
| September 30, 2015 | -42.39M |
| June 30, 2015 | -24.58M |
| March 31, 2015 | -35.08M |
| December 31, 2014 | -31.68M |
| September 30, 2014 | 61.10M |
| June 30, 2014 | -32.83M |
| March 31, 2014 | -31.39M |
| December 31, 2013 | -27.42M |
| September 30, 2013 | -22.32M |
| June 30, 2013 | -24.23M |
| March 31, 2013 | -21.20M |
| December 31, 2012 | -19.43M |
| September 30, 2012 | -19.94M |
| June 30, 2012 | -21.04M |
| March 31, 2012 | -19.40M |
| December 31, 2011 | -6.455M |
| September 30, 2011 | -16.02M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-11.87M
Minimum
Jun 2019
1.019M
Maximum
Jun 2021
-1.359M
Average
-0.437M
Median
Mar 2021
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.541M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.068M |
| Cash from Financing (Quarterly) | 0.133M |
| Free Cash Flow | -1.522M |
| Free Cash Flow Per Share (Quarterly) | -0.0206 |
| Free Cash Flow Yield | -0.71% |